Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 8206 AL 8220

Brain photobiomodulation: a potential treatment in Alzheimer's and Parkinson's diseases

Blivet G, Touchon B, Cavadore H, Guillemin S, Pain F, Weiner M, Sabbagh M, Moro C, Touchon J.

J Prev Alzheimers Dis. 2025 Aug;12(7):100185. doi: 10.1016/j.tjpad.2025.100185. Epub 2025 Apr 25.

Cholinergic therapy in Alzheimer disease

Gauthier S, Therriault J, Rosa-Neto P.

Handb Clin Neurol. 2025;211:155-159. doi: 10.1016/B978-0-443-19088-9.00015-9.

CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment

Fisher A, Levey AI.

Handb Clin Neurol. 2025;211:161-184. doi: 10.1016/B978-0-443-19088-9.00016-0.

Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease

Hasan U, Jain H, Ali R.

Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.

Targeting the redox neuroinflammatory nexus: insights into Alzheimer's and Parkinson's diseases

Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR.

Inflammopharmacology. 2025 Jul;33(7):3885-3895. doi: 10.1007/s10787-025-01831-w. Epub 2025 Jul 2.

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Neuroprotective effects of essential oils in animal models of Alzheimer's and Parkinson's disease: a systematic review

Macedo ADES, Ferreira TM, Krejcová LV, Rocha FAF, da Silva JKR, Pedrosa LRR, Gomes BD.

PeerJ. 2025 Jul 10;13:e19643. doi: 10.7717/peerj.19643. eCollection 2025.

Searching Heterocyclic Scaffolds Used to Treat Alzheimer's Disease: A Review

Kale MA, Faisal M.

Curr Drug Res Rev. 2025;17(2):266-281. doi: 10.2174/0125899775290026240612104933.

Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's

Jeyabalan JB, Pandi A V, Veintramuthu S, Sivasamy R, Dhanasekaran M, Justin A.

Neurol Sci. 2025 Oct;46(10):4779-4789. doi: 10.1007/s10072-025-08421-2. Epub 2025 Aug 26.

Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer's disease and Parkinson's disease

Liu Y, Zhang J, Tang L, Yang J, Hao L, Lou F, Su J.

Arch Toxicol. 2025 Dec;99(12):4709-4735. doi: 10.1007/s00204-025-04174-1. Epub 2025 Aug 28.

Recent synthetic advances in the preparation of 1,3-thiazole compounds and their therapeutic applications in degenerative diseases

Chaudhari P, Danta CC, Nefzi A.

Org Biomol Chem. 2025 Oct 22;23(41):9257-9284. doi: 10.1039/d5ob01199j.

Effects of monoclonal antibody therapies on depression in Parkinson's disease and Alzheimer's disease: Systematic review and meta-analysis

Gitlin-Leigh G, Wilson J, Howard R, Howard R, Costello H.

J Alzheimers Dis. 2025 Nov;108(2):500-508. doi: 10.1177/13872877251378156. Epub 2025 Sep 19.

Nanomedicine-Driven Modulation of the Gut-Brain Axis: Innovative Approaches to Managing Chronic Inflammation in Alzheimer's and Parkinson's Disease

Krsek A, Schleicher LMS, Jagodic A, Baticic L.

Int J Mol Sci. 2025 Sep 19;26(18):9178. doi: 10.3390/ijms26189178.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias